This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
Scientific Reports Open Access 27 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Joel SP, Rohatiner A . Pharmacology of antileukemic drugs. In: Henderson ES, Lister TA, Greaves MF (eds). Leukemia, Saunders: Philadelphia, PA, 2002, pp 394–440.
Hayes JD, McLellan LI . Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31: 273–300.
Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 2006; 8: R40.
Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323–3329.
Autrup JL, Hokland P, Pedersen L, Autrup H . Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia. Eur J Pharmacol 2002; 438: 15–18.
Voso MT, D'Alo F, Putzulu R, Mele L, Scardocci A, Chiusolo P et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002; 100: 2703–2707.
Naoe T, Tagawa Y, Kiyoi H, Kodera Y, Miyawaki S, Asou N et al. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia 2002; 16: 203–208.
Davies SM, Robison LL, Buckley JD, Tjoa T, Woods WG, Radloff GA et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001; 19: 1279–1287.
Acknowledgements
This investigation was supported in part by the following PHS Cooperative Agreement Grant numbers awarded by the National Cancer Institute, DHHS: CA38926, CA32102, and from a grant from the Southwest Oncology Group Hope Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weiss, J., Kopecky, K., Godwin, J. et al. Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia 20, 2169–2171 (2006). https://doi.org/10.1038/sj.leu.2404421
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404421
This article is cited by
-
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
Scientific Reports (2017)
-
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death
Cancer Chemotherapy and Pharmacology (2015)
-
GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis
Annals of Hematology (2014)